ROS-Activated homodimeric podophyllotoxin nanomedicine with self-accelerating drug release for efficient cancer eradication
Although podophyllotoxin (POD) demonstrates high efficiency to inhibit various cancers, its clinic application is limited to poor bioavailability. Nanoparticles derived from homodimeric prodrugs with high drug loading potential are emerging as promising nanomedicines. However, complete intracellular...
Saved in:
Main Authors: | Bingfeng Liang, Dangxia Zhou |
---|---|
Format: | article |
Language: | EN |
Published: |
Taylor & Francis Group
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/da7bb055d1f84c14ade51f33adb8afb5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A pH-Responsive Charge-Reversal Drug Delivery System with Tumor-Specific Drug Release and ROS Generation for Cancer Therapy
by: Xu C, et al.
Published: (2020) -
A pH-responsive prodrug delivery system of 10-HCPT for controlled release and tumor targeting
by: Liu Y, et al.
Published: (2017) -
Dexamethasone release from photopolymerised PEGDA700 for cochlea drug delivery
by: Thomas Eickner, et al.
Published: (2020) -
NIR responsive liposomal system for rapid release of drugs in cancer therapy
by: Chen MM, et al.
Published: (2017) -
Photoactivable Ruthenium-Based Coordination Polymer Nanoparticles for Light-Induced Chemotherapy
by: Junda Zhang, et al.
Published: (2021)